Knowledge Nodes
- Adicet Bio
- Adoptive cell transfer
- Allogene Therapeutics
- Allogeneic stem cell transplantation
- AlphaFold
- Antibody-drug conjugate
- Autologous stem cell transplantation
- Autolus Therapeutics
- Bacteriophage therapy
- Bioconductor
- BioMarin Pharmaceutical
- Biomarker
- Biostatistics
- Biotechnology industry
- Bispecific antibody
- BLAST (biotechnology)
- Breyanzi
- BriaCell Therapeutics
- C4 Therapeutics
- Cabaletta Bio
- CAMP4 Therapeutics
- CAR T cell
- Cartesian Therapeutics
- Cell Therapy & Immunotherapy Products
- Clinical Development & R&D Infrastructure
- Clinical trial
- Contract research organization
- CRISPR Therapeutics
- CRISPR-Cas9
- DNA sequencing
- Drug Discovery Modalities
- Enterprise value
- Fate Therapeutics
- FDA approval
- Gene Therapy Products
- Genetic engineering
- Genome Analysis Toolkit
- Genome Editing Tools
- Genotype-Tissue Expression
- Good Clinical Practice
- Google DeepMind
- Hematopoietic stem cell transplantation
- Initial public offering
- Insilico Medicine
- Insmed
- Kymriah
- Licensing agreement
- Market capitalization
- Metagenomics
- Milestone payment
- Monoclonal antibody
- Nasdaq Biotechnology Index
- Natural killer cell
- Nvidia
- Open Targets
- Parexel
- Phase III clinical trial
- Polygenic score
- Precision Oncology & Molecular Diagnostics
- PROTAC
- Protein design
- Protein structure prediction
- Proteomics & Multiomics
- REGENXBIO
- Sequencing & Genomics Technologies
- Shotgun sequencing
- Single-cell RNA sequencing
- Single-cell sequencing
- Small molecule
- SPDR S&P Biotech ETF
- Stem cell
- Synthetic Biology & Biomanufacturing
- T-cell receptor therapy
- Targeted protein degradation
- Tecartus
- Tempus AI
- Thermo Fisher Scientific
- Transcriptomics
- Venture capital
- Vertex Pharmaceuticals
- Yescarta